Did you know?

ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.  

Learn more >>

Free Newsletter

Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!

See preview >>

  Email address:
   

Changmugu Completes $3 Million Pre-A Round for AI-Orthopedics Plans

publication date: Sep 26, 2019

Changmugu, a Beijing AI-based orthopedics company, completed a $3 million Pre-A round. The company, which claims to have developed the world's first three-dimensional artificial joint replacement surgery planning system, uses AI to improve the entire process of joint replacements, including pre-op evaluation, surgical planning, 3D printing and individualized surgical navigation guidance. Changmugu will use the capital to expand its AI orthopedic products, advance the clinical registration process and support clinical use of its products. The round was led by Legend Star and joined by Frees Fund and Wanhui Capital. More details....

Share this with colleagues:


This article is available for purchase - please click here for details.

Sorry this page is available to subscribers only.
If you're not a subscriber why not subscribe today?

If you are already a subscriber, please login.

If you believe you should have received this message in error, please contact us.


 

To gain access to the members only content click here to subscribe.

You will be given immediate access to premium content on the site.

ChinaBio® News

Greg Scott BIO-Europe Interview
Greg Scott Interviewed at BIO-Europe Spring

How to bring your China assets to China in 8 minutes

Greg Scott Mendelspod Interview
"Mr. Bio in China."
Mendelspod Interview

Multinational pharma held to a higher standard in China

Partner Event
November 2-3, 2023 | Shanghai
November 7-8, 2023 | Digital